No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SLM240719P24000
- 1.20
- -2.20-64.71%
15min DelayClose Jul 15 16:00 ET
1.30High1.20Low
1.27Open3.40Pre Close3 Volume54 Open Interest24.00Strike Price377.00Turnover50.78%IV0.48%PremiumJul 19, 2024Expiry Date1.09Intrinsic Value100Multiplier3DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type-0.8094Delta0.2343Gamma19.09Leverage Ratio-0.0407Theta-0.0017Rho-15.45Eff Leverage0.0063Vega
Intraday
- 5D
- Daily
News
SLM Corp. Ratings Outlook Revised to Negative From Stable by Moody's
Express News | Shares of Companies Within the Broader Financial Sector Are Trading Higher Amid Possible Optimism Ahead of Fed President Powell's Discussion. Also, Strength May Be a Result of Investors Assessing the Impact of the Attempted Assassination of Former...
Sallie Mae to Release Second-Quarter 2024 Financial Results on July 24
Webcast Scheduled for Wednesday, July 24, at 5:30 p.m. ET Sallie Mae (NASDAQ:SLM), formally SLM Corporation, will release second-quarter 2024 financial results after market close on Wednesday, July 24, 2024. A
Deutsche Numis Maintains SLM Corp(SLM.US) With Buy Rating, Maintains Target Price $25
Deutsche Numis analyst Mark DeVries maintains $SLM Corp(SLM.US)$ with a buy rating, and maintains the target price at $25.According to TipRanks data, the analyst has a success rate of 62.8% and a
Barclays Maintains SLM Corp(SLM.US) With Buy Rating, Maintains Target Price $23
Barclays analyst Terry Ma maintains $SLM Corp(SLM.US)$ with a buy rating, and maintains the target price at $23.According to TipRanks data, the analyst has a success rate of 48.9% and a total
SLM Corp(SLM.US) Director Sells US$94,018.95 in Common Stock
$SLM Corp(SLM.US)$ Director Strong Robert S. sold 4,500 shares of common stock on Jul 1, 2024 at an average price of $20.8931 for a total value of $94,018.95.Source: Announcement What is statement of
Comments
Despite past success, the market is wary of SLM's future. The recent TSR improvement may suggest business progress. Investors should consider other factors, including potential SLM warning signs, before investing.
SLM's (NASDAQ:SLM) Five-year Earnings Growth Trails the Solid Shareholder Returns 1
Gapping up
In reaction to earnings/guidance:
• $Aehr Test Systems(AEHR.US$ +11.1% (also releases two new enhancements for its FOX-P family of wafer level test and burn-in systems)
• $Tilray Brands(TLRY.US$ +5.1%
Other news:
• $Payoneer Global(PAYO.US$ +8.1% (to join SaP SmallCap 600)
• $Atlas(ATCO.US$ +6.8% (continues negotiations with Poseidon Acquisition; parties have made meaningful progress on potential transactio...
In reaction to earnings/guidance:
• $Aehr Test Systems(AEHR.US$ +11.1% (also releases two new enhancements for its FOX-P family of wafer level test and burn-in systems)
• $Tilray Brands(TLRY.US$ +5.1%
Other news:
• $Payoneer Global(PAYO.US$ +8.1% (to join SaP SmallCap 600)
• $Atlas(ATCO.US$ +6.8% (continues negotiations with Poseidon Acquisition; parties have made meaningful progress on potential transactio...
24
Gainers:
• $Natus Medical(NTUS.US$ +28.6% (to be acquired by ArchiMed Group for $33.50/share in cash)
• $Middlefield Banc(MBCN.US$ +6.1% (Ancora Issues Open Letter to Middlefield Banc Corp. Shareholders)
• $Sinclair Broadcast Group(SBGI.US$ +5% (Sinclair Broadcast and Charter Communications (CHTR.) reach a comprehensive distribution agreement)
• $Castle Biosciences(CSTL.US$ +4.1% (announces a recent poster presentation highlighting...
• $Natus Medical(NTUS.US$ +28.6% (to be acquired by ArchiMed Group for $33.50/share in cash)
• $Middlefield Banc(MBCN.US$ +6.1% (Ancora Issues Open Letter to Middlefield Banc Corp. Shareholders)
• $Sinclair Broadcast Group(SBGI.US$ +5% (Sinclair Broadcast and Charter Communications (CHTR.) reach a comprehensive distribution agreement)
• $Castle Biosciences(CSTL.US$ +4.1% (announces a recent poster presentation highlighting...
18
Upgrades
• $Biogen(BIIB.US$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $265
• $Comerica(CMA.US$ : Baird Upgrades to Neutral from Underperform - PT $85 (from $78)
• $Delta Air Lines(DAL.US$ : UBS Upgrades to Buy from Neutral - PT $53 (from $44)
• $H.B. Fuller(FUL.US$ : Deutsche Bank Upgrades to Buy from Hold - PT $85 (from $72)
• $Gap Inc(GPS.US$ : Morgan Stanley Upgrades to EqualWeight from Underweight - PT $14
• $Zions Bancorp(ZION.US$ : Baird U...
• $Biogen(BIIB.US$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $265
• $Comerica(CMA.US$ : Baird Upgrades to Neutral from Underperform - PT $85 (from $78)
• $Delta Air Lines(DAL.US$ : UBS Upgrades to Buy from Neutral - PT $53 (from $44)
• $H.B. Fuller(FUL.US$ : Deutsche Bank Upgrades to Buy from Hold - PT $85 (from $72)
• $Gap Inc(GPS.US$ : Morgan Stanley Upgrades to EqualWeight from Underweight - PT $14
• $Zions Bancorp(ZION.US$ : Baird U...
14
Read more